Long-term results of complete clinical and pathologic regression in patients with breast cancer
https://doi.org/10.17650/1994-4098-2016-12-2-22-25
Abstract
The article presents the results of analysis of long-term treatment outcomes of 162 patients who received neoadjuvant chemotherapy for breast cancer based on City Clinical Hospital No. 40 of Ekaterinburg. ER-negative status, triple-negative subtype of tumor and lymph node negative status were found to be significant predictive factors of complete tumor regression. In studying long-term results of the treatment it was showed that negative status of lymph nodes significantly predicts improvement in relapse-free survival, while the surgical treatment does not increase relapse-free survival time in case of complete tumor regression.
About the Authors
S. M. Demidov
Municipal autonomous institution “City Clinical Hospital No. 40”;
Federal State Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of Russia
Russian Federation
Russian Federation
D. A. Demidov
Municipal autonomous institution “City Clinical Hospital No. 40”;
Federal State Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of Russia
Russian Federation
Russian Federation
M. A. Zafirova
Federal State Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Bear H.D., Anderson S., Smith R.E. et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006;24:2019–27.
2. Mauri D., Pavlidis N., Ioannidis J. P.A. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Nat Canc Inst 2005;97(3):188–94.
3. Feldman L.D., Hortobagyi G.N., Buzdar A.U. et al. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 1986;46: 2578–81.
4. Cortazar P., Zhang L., Untch M. et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. The Lancet 2014;384(9938):164–72.
5. Rastogi P., Anderson S.J., Bear H.D. et al. Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 2008;26:778–85.
6. Mamounas E.P., Anderson S.J, Dignam J.J. et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. Clin Oncol 2012;30: 3960–6.
7. Семиглазов В.Ф.. Предоперационное (неоадъювантное) лечение рака молочной железы. Медицинский альманах 2008;4: 68–70. [Semiglazov V.F. Preoperative (neoadjuvant) treatment of breast cancer. Meditsinskiy almanah = Medical Almanac 2008;4:68–70. (In Russ.)].
8. Литвяков Н.В., Гарбуков Е.Ю., Слонимская Е.М. Связь безметастатической выживаемости больных раком молочной железы и вектора изменения экспрессии генов множественной лекарственной устойчивости в опухоли при проведении неоадъювантной химиотерапии. Вопросы онкологии 2013(3):334–40. [Litvyakov N.V., Garbukov E.Yu., Slonimskaya E.M. Association of metastasis-free survival in patients with breast cancer and changes in expression vector of multidrug resistance gene in tumors during neoadjuvant chemotherapy. Voprosy onkologii = Problems in Oncology 2013(3):334– 40. (In Russ.)].
9. Семиглазов В.Ф., Семиглазов В.В., Палтуев Р.М. Неоадъювантное лечение рака молочной железы. Опухоли женской репродуктивной системы 2014;(2):30–6. [Semiglazov V.F., Semiglazov V.V., Paltuev R.M. Neoadjuvant treatment of breast cancer. Opuholi zhenskoy reproduktivnoy sistemy = Female reproductive system tumors 2014; (2):30–6. (In Russ.)].
Review
For citations:
Demidov S.M., Demidov D.A., Zafirova M.A. Long-term results of complete clinical and pathologic regression in patients with breast cancer. Tumors of female reproductive system. 2016;12(2):22-25. (In Russ.) https://doi.org/10.17650/1994-4098-2016-12-2-22-25
Views:
878
Email this article 